Prolight Diagnostics AB (publ) (NGM:PRLD)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.2430
-0.0050 (-2.02%)
At close: Jul 23, 2025
-2.02%
Market Cap174.12M
Revenue (ttm)37.40M
Net Income (ttm)-28.95M
Shares Out702.09M
EPS (ttm)-0.05
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,946,442
Average Volume3,995,011
Openn/a
Previous Close0.2480
Day's Rangen/a
52-Week Range0.1181 - 0.8092
Beta2.73
RSI45.87
Earnings DateAug 28, 2025

About Prolight Diagnostics AB

Prolight Diagnostics AB (publ) develops diagnostic systems used in point of care testing in Sweden. It engages in the development of PLD micro flex and flex membrane. Prolight Diagnostics AB (publ) was incorporated in 1999 and is based in Stockholm, Sweden. [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 1999
Employees 16
Stock Exchange Nordic Growth Market
Ticker Symbol PRLD
Full Company Profile

Financial Performance

In 2024, Prolight Diagnostics AB's revenue was 36.37 million, an increase of 50.18% compared to the previous year's 24.22 million. Losses were -26.94 million, -80.11% less than in 2023.

Financial Statements

News

There is no news available yet.